Clicky

2CUREX AB SEK-10(2QE)

Description: 2cureX AB (publ) operates as a medtech company in Europe. The company's principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.


Keywords: Cancer Pancreatic Cancer Ovarian Cancer

Home Page: www.2curex.com

Fruebjergvej 3
Copenhagen, 2100
Denmark
Phone: 45 22 11 53 99


Officers

Name Title
Mr. Ole Thastrup VD Co-Founder, CEO & Vice Chairman
Ms. Grith Hagel Co-Founder, VP of Innovation & Director
Mr. Kenneth Graabek Johansen Chief Financial Officer
Mr. Jacob Thastrup Chief Technology Officer
Mr. Manuel Fernandez Director Quality & Regulatory Affairs

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.3245
Price-to-Sales TTM: 0.3023
IPO Date:
Fiscal Year End: December
Full Time Employees: 14
Back to stocks